共 86 条
[1]
Murphy BA(2007)Systemic and global toxicities of head and neck treatment Expert Rev Anticancer Ther 7 1043-1053
[2]
Gilbert J(2022)HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management Nat Rev Clin Oncol 19 306-327
[3]
Ridner SH(2016)American cancer society head and neck cancer survivorship care guideline CA Cancer J Clin 66 203-239
[4]
Lechner M(2022)State of rehabilitation research in the head and neck cancer population: Functional impact vs. impairment-focused outcomes Curr Oncol Rep 24 517-532
[5]
Liu J(2020)The unresolved pathophysiology of lymphedema Front Physiol 11 137-1169
[6]
Masterson L(2017)A vicious circle in chronic lymphoedema pathophysiology? An adipocentric view Obes Rev 18 1159-205
[7]
Fenton TR(2016)A prospective study of the lymphedema and fibrosis continuum in patients with head and neck cancer Lymphat Res Biol 14 198-252
[8]
Cohen EE(2012)Prevalence of secondary lymphedema in patients with head and neck cancer J Pain Symptom Manage 43 244-3374
[9]
LaMonte SJ(2020)Comparing the prevalence, location, and severity of head and neck lymphedema after postoperative radiotherapy for oral cavity cancers and definitive chemoradiotherapy for oropharyngeal, laryngeal, and hypopharyngeal cancers Head Neck 42 3364-E10
[10]
Erb NL(2020)Prognostic factors for lymphedema in patients with locally advanced head and neck cancer after combined radio(chemo)therapy- results of a longitudinal study Oral Oncol 109 104856-42